Samuel Olusola

Testing and demonstrating transformative solutions increasing climate resilience of the agriculture and/or forestry sector. TOPIC ID : (HORIZON-MISS-2023-CLIMA-01) Type of action; HORIZON-IA HORIZON Innovation Actions Deadline model; single-stage Opening Date: 10 January 2023 Deadline Date; 20 September 2023 17:00:00 Brussels time Expected Outcome: Projects results are expected to contribute to all of the following expected […]

Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness. (HORIZON-HLTH-2024-DISEASE-03-11-two-stage) Deadline model: Two Stage Opening date: 26 April 2023 Deadline date: 19 September 2023, 11 April 2024 Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”.

 Implementation research/real life assessment of existing interventions in women and children’s health. (HORIZON-JU-GH-EDCTP3-2023-01-03) Deadline model: Single Stage Opening date: 10 May 2023 Deadline date: 29 June 2023. Expected Outcome:This topic aims at supporting activities that contribute to one or several of the expected impacts for this call. Proposals under this topic should aim for delivering

Comparative Effectiveness Research for Healthcare Interventions In Areas Of High Public Health Need. (HORIZON-HLTH-2024-DISEASE-03-08-two-stage) Deadline model: Two Stage Opening date: 26 April 2023 Deadline date: 19 September 2023, 11 April 2024 Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and

The Role of Environmental Pollution In Non-Communicable Diseases: Air, Noise And Light And Hazardous Waste Pollution. Call ID: (HORIZON-HLTH-2024-ENVHEALTH-02-06-two-stage) Deadline model: Two Stage Opening date: 30 March 2023 Deadline date: 19 September 2023 | 11 April 2024 Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected

Ensuring Access to Innovative, Sustainable and High-Quality Health Care (HORIZON-HLTH-2024-CARE-04-two-stage) Deadline model: Two Stage Opening date: 30 March 2023 Deadline date: 19 September 2023 | 11 April 2024 Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable

Tackling High-Burden for Patients, Under-Researched Medical Conditions (HORIZON-HLTH-2024-DISEASE-03-two-stage) Deadline model: Two Stage Opening date: 26 April 2023 Deadline date: 19 September 2023 | 11 April 2024 Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To

Validation of Fluid-Derived Biomarkers for the Prediction and Prevention of Brain Disorders (HORIZON-HLTH-2024-DISEASE-03-two-stage) Deadline model: Two Stage Opening date: 26 April 2023 Deadline date: 19 September 2023 | 11 April 2024 Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases

Holistic Support to Children and Adolescents’ Health and Care Provisions In An Increasingly Digital Society (HORIZON-HLTH-2024-STAYHLTH-01-two-stage) Deadline model: Two Stage Opening date: 30 March 2023 Deadline date: 19 September 2023 | 11 April 2024 Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several impacts of destination 1

Call ID: (HORIZON-HLTH-2023-DISEASE-07-01) Partnerships in Health- European Partnerships on Rare Diseases Call ID: (HORIZON-HLTH-2023-DISEASE-07-01) Deadline model: Single Stage Opening date: 12 January 2023 Deadline date: 19 September 2023 Expected Outcome: This topic aims at supporting activities that are enabling or contributing to several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To